Home Cart 0 Sign in  
X

[ CAS No. 1171919-00-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 1171919-00-8
Chemical Structure| 1171919-00-8
Chemical Structure| 1171919-00-8
Structure of 1171919-00-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1171919-00-8 ]

Related Doc. of [ 1171919-00-8 ]

Alternatived Products of [ 1171919-00-8 ]

Product Details of [ 1171919-00-8 ]

CAS No. :1171919-00-8 MDL No. :MFCD12498707
Formula : C5H3ClI2N2 Boiling Point : -
Linear Structure Formula :- InChI Key :ADBYPUPWCVKWCP-UHFFFAOYSA-N
M.W : 380.35 Pubchem ID :45588299
Synonyms :

Calculated chemistry of [ 1171919-00-8 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 59.09
TPSA : 38.91 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.89 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.86
Log Po/w (XLOGP3) : 2.43
Log Po/w (WLOGP) : 2.53
Log Po/w (MLOGP) : 2.24
Log Po/w (SILICOS-IT) : 3.29
Consensus Log Po/w : 2.47

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.17
Solubility : 0.0255 mg/ml ; 0.0000671 mol/l
Class : Moderately soluble
Log S (Ali) : -2.89
Solubility : 0.49 mg/ml ; 0.00129 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.12
Solubility : 0.0289 mg/ml ; 0.0000759 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.25

Safety of [ 1171919-00-8 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501 UN#:2811
Hazard Statements:H301-H311-H331 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1171919-00-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1171919-00-8 ]
  • Downstream synthetic route of [ 1171919-00-8 ]

[ 1171919-00-8 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 14432-12-3 ]
  • [ 800402-12-4 ]
  • [ 909036-46-0 ]
  • [ 1171919-00-8 ]
YieldReaction ConditionsOperation in experiment
49.7% With potassium acetate; Iodine monochloride In acetic acid at 70℃; for 4 h; Inert atmosphere A mixture of 2-chloro-4-amino pyridine 1 (20g, 0.15mol), potassium acetate (22.9g, 0.23mol) and ICl (27.7g, 0.17mol) in glacial acetic acid (200mL) was heated to 70°C for 4h. The solvent was concentrated under reduced pressure. The residue was neutralized with 10percent NaHCO3 solution (250mL) and extracted with two 300-mL portions of EtOAc. The combined organic extracts were washed with brine (200mL) and dried over anhydrous Na2SO4. The solvent was removed in vacuum. The crude product showed a mixture of iodopyridines 2, 3 and 4 in the ratio 45:45:10. The required compound 2 (elution 2) was isolated via normal phase preparative HPLC (mobile phase: 60:40, 0.1percent TFA in hexane-IPA; column: SunFire Silica 19*150mm, 5μm; Flow rate: 18.0mL/min) in 49.7percent yield (19.7g) as an off white solid.
49.7% at 70℃; for 4 h; Inert atmosphere A mixture of 2-chloro-4-amino pyridine 1 (20g, 0.15mol), potassium acetate (22.9g, 0.23mol) and ICl (27.7g, 0.17mol) in glacial acetic acid (200mL) was heated to 70°C for 4h. After completion of the reaction, the solvent was concentrated under reduced pressure. The residue was neutralized with 10percent NaHCO3 solution (250mL) and extracted with two 300-mL portions of EtOAc. The combined organic extracts were washed with brine (200mL) and dried over anhydrous Na2SO4. The solvent was removed in vacuum. The crude product showed a mixture of iodopyridines 2, 3 and 4 in the ratio 45:45:10. The required compound 2 (elution 3) was isolated via normal phase preparative HPLC (mobile phase: 60:40, 0.1percent TFA in hexane-IPA; column: SunFire Silica 19×150mm, 5μm; Flow rate: 18.0mL/min) in 49.7percent yield (19.7g) as an off white solid; mp 102.9–104.1°C; 1H NMR (400MHz, DMSO-D6): δ 7.73 (d, J=4.0Hz, 1H), 6.52 (d, J=4.0Hz, 1H), 6.50 (s, 2H); MS (m/z): 255.0 [M+H]+. Anal. calcd. for C5H4ClIN2: C, 23.60; H, 1.58; N, 11.01; found: C, 23.59; H, 1.578; N, 10.99
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 77, p. 288 - 297
[2] Journal of Molecular Structure, 2014, vol. 1081, p. 85 - 95
[3] Journal of Organic Chemistry, 2012, vol. 77, # 11, p. 5006 - 5016
[4] European Journal of Medicinal Chemistry, 2017, vol. 131, p. 275 - 288
  • 2
  • [ 14432-12-3 ]
  • [ 800402-12-4 ]
  • [ 1171919-00-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 23, p. 9382 - 9394
  • 3
  • [ 14432-12-3 ]
  • [ 800402-12-4 ]
  • [ 909036-46-0 ]
  • [ 1171919-00-8 ]
YieldReaction ConditionsOperation in experiment
49.7% With potassium acetate; Iodine monochloride In acetic acid at 70℃; for 4 h; Inert atmosphere A mixture of 2-chloro-4-amino pyridine 1 (20g, 0.15mol), potassium acetate (22.9g, 0.23mol) and ICl (27.7g, 0.17mol) in glacial acetic acid (200mL) was heated to 70°C for 4h. The solvent was concentrated under reduced pressure. The residue was neutralized with 10percent NaHCO3 solution (250mL) and extracted with two 300-mL portions of EtOAc. The combined organic extracts were washed with brine (200mL) and dried over anhydrous Na2SO4. The solvent was removed in vacuum. The crude product showed a mixture of iodopyridines 2, 3 and 4 in the ratio 45:45:10. The required compound 2 (elution 2) was isolated via normal phase preparative HPLC (mobile phase: 60:40, 0.1percent TFA in hexane-IPA; column: SunFire Silica 19*150mm, 5μm; Flow rate: 18.0mL/min) in 49.7percent yield (19.7g) as an off white solid.
49.7% at 70℃; for 4 h; Inert atmosphere A mixture of 2-chloro-4-amino pyridine 1 (20g, 0.15mol), potassium acetate (22.9g, 0.23mol) and ICl (27.7g, 0.17mol) in glacial acetic acid (200mL) was heated to 70°C for 4h. After completion of the reaction, the solvent was concentrated under reduced pressure. The residue was neutralized with 10percent NaHCO3 solution (250mL) and extracted with two 300-mL portions of EtOAc. The combined organic extracts were washed with brine (200mL) and dried over anhydrous Na2SO4. The solvent was removed in vacuum. The crude product showed a mixture of iodopyridines 2, 3 and 4 in the ratio 45:45:10. The required compound 2 (elution 3) was isolated via normal phase preparative HPLC (mobile phase: 60:40, 0.1percent TFA in hexane-IPA; column: SunFire Silica 19×150mm, 5μm; Flow rate: 18.0mL/min) in 49.7percent yield (19.7g) as an off white solid; mp 102.9–104.1°C; 1H NMR (400MHz, DMSO-D6): δ 7.73 (d, J=4.0Hz, 1H), 6.52 (d, J=4.0Hz, 1H), 6.50 (s, 2H); MS (m/z): 255.0 [M+H]+. Anal. calcd. for C5H4ClIN2: C, 23.60; H, 1.58; N, 11.01; found: C, 23.59; H, 1.578; N, 10.99
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 77, p. 288 - 297
[2] Journal of Molecular Structure, 2014, vol. 1081, p. 85 - 95
[3] Journal of Organic Chemistry, 2012, vol. 77, # 11, p. 5006 - 5016
[4] European Journal of Medicinal Chemistry, 2017, vol. 131, p. 275 - 288
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1171919-00-8 ]

Chlorides

Chemical Structure| 909036-46-0

[ 909036-46-0 ]

2-Chloro-3-iodopyridin-4-amine

Similarity: 0.98

Chemical Structure| 1235873-11-6

[ 1235873-11-6 ]

2,6-Dichloro-3-iodopyridin-4-amine

Similarity: 0.96

Chemical Structure| 800402-12-4

[ 800402-12-4 ]

2-Chloro-5-iodo-4-pyridinamine

Similarity: 0.92

Chemical Structure| 856169-60-3

[ 856169-60-3 ]

2-Chloro-3,5-diiodopyridine

Similarity: 0.80

Amines

Chemical Structure| 909036-46-0

[ 909036-46-0 ]

2-Chloro-3-iodopyridin-4-amine

Similarity: 0.98

Chemical Structure| 1235873-11-6

[ 1235873-11-6 ]

2,6-Dichloro-3-iodopyridin-4-amine

Similarity: 0.96

Chemical Structure| 800402-12-4

[ 800402-12-4 ]

2-Chloro-5-iodo-4-pyridinamine

Similarity: 0.92

Iodides

Chemical Structure| 909036-46-0

[ 909036-46-0 ]

2-Chloro-3-iodopyridin-4-amine

Similarity: 0.98

Chemical Structure| 1235873-11-6

[ 1235873-11-6 ]

2,6-Dichloro-3-iodopyridin-4-amine

Similarity: 0.96

Chemical Structure| 800402-12-4

[ 800402-12-4 ]

2-Chloro-5-iodo-4-pyridinamine

Similarity: 0.92

Chemical Structure| 856169-60-3

[ 856169-60-3 ]

2-Chloro-3,5-diiodopyridine

Similarity: 0.80

Related Parent Nucleus of
[ 1171919-00-8 ]

Pyridines

Chemical Structure| 909036-46-0

[ 909036-46-0 ]

2-Chloro-3-iodopyridin-4-amine

Similarity: 0.98

Chemical Structure| 1235873-11-6

[ 1235873-11-6 ]

2,6-Dichloro-3-iodopyridin-4-amine

Similarity: 0.96

Chemical Structure| 800402-12-4

[ 800402-12-4 ]

2-Chloro-5-iodo-4-pyridinamine

Similarity: 0.92

Chemical Structure| 856169-60-3

[ 856169-60-3 ]

2-Chloro-3,5-diiodopyridine

Similarity: 0.80